Graham P. Allaway

8.0k citations

47 papers · 6.6k indexed · 3 hit papers · h-index 30

Virology top 0.05%
- HIV Research and Treatment 22
Immunology top 0.5%
- Immune Cell Function and Interaction 11
Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment 19
- HIV/AIDS Research and Interventions 4
Radiology, Nuclear Medicine and Imaging top 2%
- Monoclonal and Polyclonal Antibodies Research 7
Hepatology top 5%
Organic Chemistry
- Carbohydrate Chemistry and Synthesis 9
Molecular Biology
- Viral Infectious Diseases and Gene Expression in Insects 6
- Natural product bioactivities and synthesis 5

Co-authors: Paul J. Maddon Tatjana Dragic Kirsten Nagashima Richard A. Koup Virginia Litwin William A. Paxton JOHN P. MOORE Yaoxing Huang
Cited by: Virology Immunology Infectious Diseases
Journals: Nature (2 papers)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)
Partner nations: United States Canada United Kingdom

In The Last Decade

Graham P. Allaway

46 papers receiving 6.5k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Graham P. Allaway

Since Specialization

Citations

This map shows the geographic impact of Graham P. Allaway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham P. Allaway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham P. Allaway more than expected).

Fields of papers citing papers by Graham P. Allaway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham P. Allaway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham P. Allaway. The network helps show where Graham P. Allaway may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Graham P. Allaway, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Graham P. Allaway Line = papers co-authored together Graham P. Allaway links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Design and development of innovative microparticulate/nanoparticulate inhalable dry powders of a novel synthetic trifluorinated chalcone derivative and Nrf2 agonist Scientific Reports ·Priya Muralidharan,Brielle Jones,Graham P. Allaway,Shyam Biswal,Heidi M. Mansour	2020	7
2	Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative Translational research ·Jun Wei,Hongyan Zhu,Gabriel Lord,Mitra Bhattachayya,Brielle Jones,Graham P. Allaway,Shyam Biswal,Benjamin D. Korman,Roberta Gonçalves Marangoni,Warren G. Tourtellotte,John Varga	2016	29
3	Elevated temperature triggers human respiratory syncytial virus F protein six-helix bundle formation Virology ·Abdul S. Yunus,Trent P. Jackson,Katherine Crisafi,Irina Burimski,Nicole Kilgore,Dorian Zoumplis,Graham P. Allaway,Carl Wild,Karl Salzwedel	2009	35
4	Anti-AIDS agents 73: Structure–activity relationship study and asymmetric synthesis of 3-O-monomethylsuccinyl-betulinic acid derivatives Bioorganic & Medicinal Chemistry Letters ·Keduo Qian,Kyoko Nakagawa‐Goto,Donglei Yu,Susan L. Morris‐Natschke,Theodore J. Nitz,Nicole Kilgore,Graham P. Allaway,Kuo‐Hsiung Lee	2007	29
5	Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-hu Thy/Liv Mice PLoS ONE ·Cheryl A. Stoddart,Pheroze Joshi,Barbara Sloan,Jennifer C. Bare,Philip C. Smith,Graham P. Allaway,Carl Wild,David E. Martin	2007	36
6	Determinants of activity of the HIV-1 maturation inhibitor PA-457 Virology ·Feng Li,Dorian Zoumplis,Claudia Matallana,Nicole Kilgore,Mary Reddick,Abdul S. Yunus,Catherine S. Adamson,Karl Salzwedel,David E. Martin,Graham P. Allaway,Eric O. Freed,Carl Wild	2006	56
7	Computational Studies and Drug Design for HIV-1 Reverse Transcriptase Inhibitors of 3′,4′-di-O-(S)-camphanoyl-(+)-cis-Khellactone (DCK) Analogs Journal of Computer-Aided Molecular Design ·Hai-feng Chen,Bo‐Tao Fan,Chen-yang Zhao,Lan Xie,Chun-hong Zhao,Ting Zhou,Kuo‐Hsiung Lee,Graham P. Allaway	2005	7
8	The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV Expert Opinion on Investigational Drugs ·Donglei Yu,Carl Wild,David E. Martin,Susan L. Morris‐Natschke,Chin‐Ho Chen,Graham P. Allaway,Kuo‐Hsiung Lee	2005	41
9	3-O-Glutaryl-dihydrobetulin and related monoacyl derivatives as potent anti-HIV agents Bioorganic & Medicinal Chemistry Letters ·Yoshiki Kashiwada,Michiko Sekiya,Yasumasa Ikeshiro,Toshihiro Fujioka,Nicole Kilgore,Carl Wild,Graham P. Allaway,Kuo‐Hsiung Lee	2004	23
10	Anti-AIDS agents. Part 47: synthesis and anti-HIV activity of 3-substituted 3′,4′-Di-O-(S)-camphanoyl-(3′R,4′R)-(+)-cis-khellactone derivatives Bioorganic & Medicinal Chemistry Letters ·Lan Xie,Graham P. Allaway,Carl Wild,Nicole Kilgore,Kuo-Hsiung Lee	2001	7
11	AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptorbreakdown → Nature Medicine ·G A Donzella,Dominique Schols,Steven Lin,José A. Esté,Kirsten Nagashima,Paul J. Maddon,Graham P. Allaway,Thomas P. Sakmar,Geoffrey Henson,Erik De Clercq,John P. Moore	1998	634
12	HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5breakdown → Nature ·Tatjana Dragic,Virginia Litwin,Graham P. Allaway,Scott R. Martin,Yaoxing Huang,Kirsten Nagashima,Charmagne Cayanan,Paul J. Maddon,Richard A. Koup,JOHN P. MOORE,William A. Paxton	1996	2625
13	CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5breakdown → Nature ·Alexandra Trkola,Tatjana Dragic,James Arthos,James Μ. Binley,William C. Olson,Graham P. Allaway,Cecilia Cheng‐Mayer,James E. Robinson,Paul J. Maddon,John P. Moore	1996	922
14	Expression and Characterization of CD4-IgG ₂ , a Novel Heterotetramer That Neutralizes Primary HIV Type 1 Isolates AIDS Research and Human Retroviruses ·Graham P. Allaway,Karen Davis‐Bruno,Gary A. Beaudry,ELISA B. GARCIA,EMILY L. WONG,Andrew M. Ryder,Karl W. Hasel,Marie‐Claire Gauduin,Richard A. Koup,J. Steven McDougal,Paul J. Maddon	1995	198
15	Synergistic Inhibition of HIV-1 Envelope-Mediated Cell Fusion by CD4-Based Molecules in Combination with Antibodies to gp120 or gp41 AIDS Research and Human Retroviruses ·Graham P. Allaway,Andrew M. Ryder,Gary A. Beaudry,Paul J. Maddon	1993	32
16	Prokaryotic expression of the thyrotropin receptor and identification of an immunogenic region of the protein using synthetic peptides Biochemical and Biophysical Research Communications ·Osamu Takai,Rajesh K. Desai,Gattadahalli S. Seetharamaiah,Craig A. Jones,Graham P. Allaway,Takashi Akamizu,Leonard D. Kohn,B S Prabhakar	1991	61
17	A Potential for Mutual Regulation of Proopiomelanocortin Gene and Epstein‐Barr Virus Expression in Human Lymphocytes Annals of the New York Academy of Sciences ·Edward L. Oates,Graham P. Allaway,Bellur S. Prabhakar	1990	6
18	Cell surface expression of the 70-kD component of Ku, a DNA-binding nuclear autoantigen. Journal of Clinical Investigation ·Bellur S. Prabhakar,Graham P. Allaway,J. Srinivasappa,Abner Louis Notkins	1990	87
19	Characterization of the 70kDa component of the human Ku autoantigen expressed in insect cell nuclei using a recombinant baculovirus vector Biochemical and Biophysical Research Communications ·Graham P. Allaway,Alfred A. Vivino,Leonard D. Kohn,Abner Louis Notkins,S. Prabhakar Bellur	1990	35
20	Spontaneously Proliferating Human B Lymphocytes Make Autoantibodies The Journal of Infectious Diseases ·Graham P. Allaway,J. Srinivasappa,Frederick W. Miller,Bellur S. Prabhakar,Abner Louis Notkins	1988	8

About Graham P. Allaway

Graham P. Allaway is a scholar working on Virology, Infectious Diseases and Immunology, having authored 47 papers that have together received 6.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (19 papers), Immune Cell Function and Interaction (11 papers), Carbohydrate Chemistry and Synthesis (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers), Natural product bioactivities and synthesis (5 papers) and HIV/AIDS Research and Interventions (4 papers). The work is most often cited by research in Virology (4.8k citations), Immunology (3.2k citations) and Infectious Diseases (2.3k citations). Graham P. Allaway has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Paul J. Maddon, Tatjana Dragic, Kirsten Nagashima, Richard A. Koup, Virginia Litwin, William A. Paxton, JOHN P. MOORE, Yaoxing Huang, Charmagne Cayanan and John P. Moore. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact